The authorisation holder keeps the list provided for in 1° of Article R. 5139-3 up to date and sends it to the Agence nationale de sécurité du médicament et des produits de santé by 15 February each year at the latest. Any change to this list during the year is immediately notified to the Director General of the Agency.